H20.013

🧬ICD-10-CM H20.013 - Primary Iridocyclitis, Bilateral

⚠️ Note: H20.013 is an ICD-10-CM diagnosis code, not a CPT procedure code. Fields such as wRVU, global period, and assistant payable do not apply to diagnosis codes. Bilateral procedures carry modifier -50 (or separate -RT/-LT line items per payer preference) — see Associated CPT Procedures section.

🔗 Laterality Cross-Reference: H20.013 (bilateral) is the simultaneous bilateral counterpart to H20.011 (right eye) and H20.012 (left eye). All clinical definitions, tabular Includes, Excludes 1/2, HCC associations, and MS-DRG mappings share the same parent category. The bilateral designation is clinically distinct and diagnostically significant — bilateral simultaneous anterior uveitis carries a different and more urgent differential diagnosis than unilateral disease. Do not report H20.011 + H20.012 together for a simultaneous bilateral episode — use H20.013.

---

Short Definition

Primary iridocyclitis, bilateral — simultaneous acute or subacute inflammatory disease of the iris and ciliary body affecting both eyes at the same time, with no confirmed underlying systemic, infectious, or traumatic etiology at the time of diagnosis. The bilateral simultaneous presentation is clinically significant and demands urgent systemic investigation.

---

Long / Clinical Definition

Iridocyclitis is inflammation of the anterior uveal tract — specifically the iris and ciliary body — and is synonymous with anterior uveitis. When it affects both eyes simultaneously, this is designated bilateral iridocyclitis. The prefix “primary” in H20.013 indicates the absence of a confirmed etiologic diagnosis at the time of coding.

Why Bilateral Is Clinically Distinct

Bilateral simultaneous anterior uveitis is fundamentally different from alternating unilateral disease in its clinical implications:

Feature	Unilateral Anterior Uveitis (H20.011/012)	Bilateral Simultaneous Anterior Uveitis (H20.013)
Most common etiology	HLA-B27 spondyloarthropathy (AS, ReA, PsA, IBD-related)	Sarcoidosis, JIA, Behçet’s, syphilis, VKH, herpes (bilateral)
Systemic urgency	Moderate — workup important but less emergent	HIGH — bilateral simultaneous uveitis is a red flag for significant systemic disease
Granulomatous likelihood	Less common (fine KPs typically)	More common (mutton-fat KPs in sarcoid, VKH, TB)
Infectious etiology risk	Lower in HLA-B27 typical cases	Higher for syphilis, TB, viral (CMV, HSV bilateral)
Vision threat	Significant	Greater — both eyes at risk simultaneously
Inpatient admission likelihood	Low for isolated episode	Higher — systemic disease often requires admission-level workup/treatment
Typical patient	Adult male, HLA-B27+, young to middle age	Variable — depends on etiology; JIA in children, sarcoid in adults

Bilateral Simultaneous vs. Bilateral Sequential

Critical Coding Distinction:

Presentation	Code	Rationale
Both eyes simultaneously active at the same encounter	H20.013	Bilateral simultaneous — one code captures both
Right eye active at one encounter, left eye active at a later encounter (different dates)	H20.011 or H20.012 at respective encounters	Sequential alternating — each episode coded by the eye active at that visit
Both eyes currently active but with asymmetric onset (right eye onset 2 weeks ago + left eye newly active today)	H20.013	Both eyes documented as active at this encounter — use bilateral
Right eye chronic iridocyclitis + left eye new acute episode	H20.11 (right) + H20.012 (left)	Two co-existing but distinct conditions — dual-code is appropriate here since the clinical status differs

Etiologic Classification: Bilateral Differential

When bilateral simultaneous anterior uveitis is coded as H20.013 (primary/idiopathic), the following etiologies should be actively pursued:

Etiology	Key Diagnostic Features	ICD-10-CM Code When Confirmed
Sarcoidosis	Mutton-fat KPs, posterior involvement, hilar adenopathy, elevated ACE/serum calcium, biopsy	D86.83 (Excludes 1 — replaces H20.013)
Juvenile idiopathic arthritis (JIA)	Children; ANA+; chronic asymptomatic; polyarticular or oligoarticular	H20.043 + M08.x
Behçet’s disease	Oral/genital ulcers, hypopyon, skin lesions, pathergy	M35.2 + H20.013/H20.053
Syphilis (secondary)	RPR+/FTA-ABS+, rash, mucosal lesions	A51.43 (Excludes 1 — replaces H20.013)
Vogt-Koyanagi-Harada (VKH) Syndrome	Granulomatous bilateral anterior + posterior uveitis, meningismus, skin/hair depigmentation	H20.823 (replaces H20.013)
IBD (Crohn’s / UC)	GI symptoms, bowel disease, HLA-B27+ subset	H20.043 + K50.x/K51.x
Reactive arthritis (ReA)	Post-infectious (STI, enteric); urethritis, arthritis, conjunctivitis	H20.043 + M02.3x
Tuberculosis	TB exposure, positive QuantiFERON, CXR changes	A18.54 (Excludes 1 — replaces H20.013)
Lyme disease	Endemic area, tick exposure, rash, arthritis, neurological signs	A69.22
Psoriatic arthritis	Skin psoriasis, asymmetric arthritis, nail changes	H20.043 + M07.x
MS (uveitis overlap)	Neurological findings, white matter lesions on MRI	H20.043 + G35.-
Herpes bilateral (CMV, HSV)	Immunocompromised; CMV retinitis overlap; stellate KPs; iris atrophy	B00.51 or appropriate CMV code (Excludes 1)

Clinical Presentation (Bilateral)

Feature	Bilateral Finding
Onset	Simultaneous or near-simultaneous; may be asymmetric in severity
Pain	Bilateral periocular pain; may be asymmetric
Photophobia	Bilateral; often more severe than unilateral
Visual Impact	Greater — both visual fields threatened
Pupils	Bilateral miosis; may be asymmetric; posterior synechiae possible
IOP	Bilateral monitoring essential — trabeculitis may be asymmetric
KP Pattern	May differ between eyes (right eye fine KPs vs. left eye mutton-fat = mixed granulomatous/nongranulomatous)
Posterior Segment	Bilateral dilated fundus exam critical — posterior spillover, disc edema, CME

---

Area of the Body

• Primary Structures: Iris and ciliary body of both eyes simultaneously — anterior uveal tract, bilateral
• Secondary Structures at Risk (Bilateral):
  • Both anterior chambers (cells, flare, hypopyon)
  • Both corneal endothelia (bilateral KP formation)
  • Both lenses (bilateral posterior synechiae; bilateral uveitic cataract risk)
  • Both trabecular meshworks (bilateral trabeculitis; bilateral IOP elevation risk)
  • Both maculas (bilateral CME — most vision-threatening bilateral complication)
  • Both optic nerves (bilateral disc edema in severe cases)
  • Both vitreous bodies (bilateral anterior spillover in severe disease)
• Vascular Supply: Bilateral long posterior ciliary arteries and anterior ciliary arteries (branches of bilateral ophthalmic arteries)
• Innervation: Bilateral CN III (parasympathetic → sphincter pupillae); bilateral sympathetic (dilator pupillae)
• Systemic Connection: Bilateral simultaneous anterior uveitis frequently represents the ophthalmic manifestation of a systemic disease (sarcoidosis, JIA, IBD, Behçet’s, VKH, syphilis) and should be approached as a systemic problem requiring multidisciplinary evaluation
• Anatomic Layers Involved: Anterior uvea bilaterally; spillover into vitreous bilaterally in severe cases

---

Code Tree / Hierarchy

ICD-10-CM (FY2026)  
└── Chapter VII - Diseases of the Eye and Adnexa (H00-H59)  
└── H15-H22 - Disorders of Sclera, Cornea, Iris and Ciliary Body  
└── H20 - Iridocyclitis (non-billable header)  
├── H20.0 - Acute and Subacute Iridocyclitis (non-billable)  
│ ├── H20.00 - Unspecified acute and subacute iridocyclitis  
│ │ ├── H20.001 - right eye  
│ │ ├── H20.002 - left eye  
│ │ ├── H20.003 - bilateral  
│ │ └── H20.009 - unspecified ⚠️ Avoid  
│ ├── H20.01 - PRIMARY Iridocyclitis (non-billable parent)  
│ │ ├── H20.011 - right eye  
│ │ ├── H20.012 - left eye  
│ │ ├── H20.013 - bilateral ✅ ← THIS CODE  
│ │ └── H20.019 - unspecified ⚠️ Avoid — laterality required  
│ ├── H20.02 - RECURRENT ACUTE Iridocyclitis (non-billable parent)  
│ │ ├── H20.021 - right eye  
│ │ ├── H20.022 - left eye  
│ │ ├── H20.023 - bilateral ✅ (upgrade from H20.013 when recurrence established)  
│ │ └── H20.029 - unspecified  
│ ├── H20.03 - SECONDARY INFECTIOUS Iridocyclitis (non-billable parent)  
│ │ ├── H20.031 - right eye  
│ │ ├── H20.032 - left eye  
│ │ ├── H20.033 - bilateral ✅ (confirmed infectious etiology, bilateral)  
│ │ └── H20.039 - unspecified  
│ ├── H20.04 - SECONDARY NONINFECTIOUS Iridocyclitis (non-billable parent)  
│ │ ├── H20.041 - right eye  
│ │ ├── H20.042 - left eye  
│ │ ├── H20.043 - bilateral ✅ (confirmed systemic autoimmune etiology, bilateral)  
│ │ └── H20.049 - unspecified  
│ └── H20.05 - Hypopyon (non-billable parent)  
│ ├── H20.051 - right eye  
│ ├── H20.052 - left eye  
│ ├── H20.053 - bilateral ✅ (use instead of H20.013 when bilateral hypopyon documented)  
│ └── H20.059 - unspecified  
├── H20.1 - Chronic Iridocyclitis (non-billable parent)  
│ ├── H20.10 - unspecified ✅  
│ ├── H20.11 - right eye ✅  
│ ├── H20.12 - left eye ✅  
│ └── H20.13 - bilateral ✅ (upgrade from H20.013 when duration ≥ 3 months)  
├── H20.2 - Lens-Induced Iridocyclitis  
│ ├── H20.20 - unspecified ✅  
│ ├── H20.21 - right eye ✅  
│ ├── H20.22 - left eye ✅  
│ └── H20.23 - bilateral ✅  
├── H20.8 - Other Iridocyclitis  
│ ├── H20.81 - Fuchs' heterochromic cyclitis  
│ │ ├── H20.811 - right eye ✅  
│ │ ├── H20.812 - left eye ✅  
│ │ ├── H20.813 - bilateral ✅ (rare — Fuchs' is almost always unilateral)  
│ │ └── H20.819 - unspecified ✅  
│ └── H20.82 - Vogt-Koyanagi-Harada Syndrome  
│ ├── H20.821 - right eye ✅  
│ ├── H20.822 - left eye ✅  
│ ├── H20.823 - bilateral ✅ (VKH is almost always bilateral — use over H20.013 when VKH confirmed)  
│ └── H20.829 - unspecified ✅  
└── H20.9 - Unspecified Iridocyclitis ✅

Bilateral-Relevant Etiology Codes (Excludes 1 Cross-Reference for H20.013):
├── D86.83 - Sarcoidosis of eye (replaces H20.013 when confirmed — Excludes 1)
├── A51.43 - Secondary syphilitic iridocyclitis (replaces H20.013 — Excludes 1)
├── A52.71 - Late syphilitic iridocyclitis (replaces H20.013 — Excludes 1)
├── A18.54 - Tuberculous iridocyclitis (replaces H20.013 — Excludes 1)
├── B00.51 - Herpes simplex iridocyclitis (replaces H20.013 — Excludes 1)
├── B02.32 - Zoster iridocyclitis (replaces H20.013 — Excludes 1)
├── B58.09 - Toxoplasmic iridocyclitis (replaces H20.013 — Excludes 1)
├── H20.823 - VKH syndrome, bilateral (use when VKH confirmed over H20.013)
└── M35.2 - Behçet's disease (code + H20.013/H20.053 when confirmed)

---

ICD-10-CM Tabular Includes & Excludes

Includes (at H20.0 Subcategory Level — Applies to H20.013)

Per the ICD-10-CM FY2026 Tabular List, the following are included under H20.0 and apply to H20.013:

• Acute anterior uveitis, bilateral (primary)
• Acute iritis, bilateral (primary)
• Acute cyclitis, bilateral (primary)
• Subacute anterior uveitis, bilateral (primary)
• Subacute iritis, bilateral (primary)
• Subacute cyclitis, bilateral (primary)
• Idiopathic anterior uveitis, bilateral (acute/subacute, no confirmed etiology)
• Simultaneous bilateral nongranulomatous anterior uveitis (primary/idiopathic)
• Simultaneous bilateral granulomatous anterior uveitis (primary/idiopathic) — when workup is underway and no etiology yet confirmed

Excludes 1 (at H20.0 Category Level — Cannot Code Simultaneously)

Excludes 1 = NOT CODED HERE. These etiology-specific codes replace H20.013 entirely when the confirmed diagnosis is established. They cannot coexist with H20.013 on the same claim for the same bilateral condition.

Excluded Code	Confirmed Etiology	Correct Code
B00.51	Herpes simplex bilateral iridocyclitis	B00.51 - Herpes simplex iridocyclitis (lateral code if available)
B02.32	Herpes zoster bilateral iridocyclitis	B02.32 - Zoster iridocyclitis
A18.54	Tuberculous bilateral iridocyclitis	A18.54 - TB iridocyclitis
A52.71	Late syphilitic bilateral iridocyclitis	A52.71 - Late syphilis eye
A51.43	Secondary syphilitic bilateral iridocyclitis	A51.43 - Secondary syphilis eye
A50.39	Late congenital syphilitic bilateral iridocyclitis	A50.39 - Congenital syphilis eye
A54.32	Gonococcal bilateral iridocyclitis	A54.32
A36.89	Diphtheritic bilateral iridocyclitis	A36.89
B58.09	Toxoplasmic bilateral iridocyclitis	B58.09
D86.83	Sarcoidosis with bilateral iridocyclitis	D86.83 - Sarcoidosis of eye (single code covers bilateral ocular sarcoid)

Note

⚠️ Bilateral Uveitis + Sarcoidosis = D86.83, not H20.013. Sarcoidosis is one of the top three etiologies of bilateral anterior uveitis in adults. Once sarcoidosis is confirmed, D86.83 replaces H20.013 entirely. D86.83 is an Excludes 1 code from H20.0x — they cannot coexist. The same logic applies to bilateral TB uveitis (A18.54), bilateral syphilitic uveitis (A51.43 or A52.71), and bilateral herpes uveitis (B00.51/B02.32). Bilateral presentation makes all of these etiologies more likely — pursue them aggressively before leaving the diagnosis as H20.013 (primary/idiopathic).

Excludes 2 (at H20 Category Level — May Code Together)

Excludes 2 = Not included here but may be reported alongside H20.013 when both conditions are present.

Excluded Code	Description	Coding Guidance with H20.013
H40.40x-H40.43x	Glaucoma secondary to eye inflammation (bilateral)	✅ Code together — bilateral inflammatory glaucoma; use H40.403 or appropriate bilateral code
H26.x (bilateral)	Complicated cataract, bilateral	✅ Bilateral uveitic cataract
H35.813	Bilateral cystoid macular edema	✅ Bilateral CME secondary to bilateral uveitis
H21.52x (bilateral)	Posterior synechiae	✅ Bilateral iris-lens adhesions
H18.423	Band-shaped keratopathy, bilateral	✅ Bilateral calcium band keratopathy
H44.133	Sympathetic uveitis, bilateral	✅ If sympathetic mechanism confirmed bilaterally
M35.2	Behçet’s disease	✅ Code Behçet’s + H20.013/H20.053 when confirmed — Behçet’s is NOT Excludes 1 from H20.0x
K50.x	Crohn’s disease	✅ When IBD-associated uveitis confirmed, transition to H20.043 + K50.x
K51.x	Ulcerative colitis	✅ Same — transition to H20.043 + K51.x

Use Additional Code Conventions (Bilateral-Specific)

Situation	Additional Codes
Bilateral glaucoma complication	H40.403 (secondary glaucoma, bilateral — or specify stage)
Behçet’s disease confirmed	M35.2 + retain H20.013/H20.053; Behçet’s is not in the Excludes 1 list
Systemic steroid treatment	Z79.52 (long-term systemic steroids)
Biologic agent / immunosuppressive treatment	Z79.899 (long-term other medication)
Organism confirmed bilaterally	B95.x/B96.x organism codes (unless Excludes 1 code applies)

---

Bilateral-Specific Code Decision Map

Clinical Scenario	Correct Code	Key Reason
Both eyes simultaneously active, first episode, no etiology confirmed	H20.013 ✅	Primary bilateral — workup pending
Both eyes active — confirmed sarcoidosis	D86.83	Excludes 1 — sarcoid replaces H20.013
Both eyes active — confirmed secondary syphilis	A51.43	Excludes 1
Both eyes active — confirmed TB	A18.54	Excludes 1
Both eyes active — confirmed VKH syndrome	H20.823	VKH has its own specific bilateral code — more specific than H20.013
Both eyes active — confirmed Behçet’s	M35.2 + H20.053	Behçet’s + hypopyon (if present) — H20.013 acceptable if no hypopyon
Both eyes active — confirmed JIA	H20.043 + M08.x	Secondary noninfectious bilateral
Both eyes active — confirmed IBD (Crohn’s/UC)	H20.043 + K50.x/K51.x	Secondary noninfectious bilateral
Both eyes active — confirmed AS	H20.043 + M45.x	Note: bilateral simultaneous AS uveitis is less typical but occurs
Prior history of bilateral, now recurrent bilateral episode	H20.023	Recurrent acute bilateral — upgrade from H20.013
Duration of bilateral inflammation ≥ 3 months	H20.13	Chronic bilateral — upgrade
Bilateral hypopyon documented	H20.053	Hypopyon bilateral — use instead of H20.013
Right eye chronic + left eye new acute episode	H20.11 + H20.012	Dual coding appropriate — different clinical states per eye
Right eye active at this visit; left eye flared last month (resolved)	H20.011 or H20.012	Code only the currently active eye — alternate episodes use unilateral codes
Both eyes examined but only one currently active	H20.011 or H20.012	Code the active eye only — bilateral code requires both eyes to be simultaneously active

---

HCC Status & Risk Adjustment

Direct HCC Status of H20.013

Item	Value
CMS-HCC V28 Direct Mapping	❌ Not directly mapped to HCC
HHS-HCC (ACA Exchange Plans)	❌ Not mapped
RAF Score Contribution (standalone)	$0 additional RAF

Note

💡Bilateral Uveitis Raises the HCC Stakes. Bilateral simultaneous anterior uveitis is a stronger clinical signal for an underlying systemic HCC-mapped condition than unilateral disease. The systemic etiologies most strongly associated with bilateral anterior uveitis — sarcoidosis, JIA, IBD, Behçet’s, syphilis — are either HCC-mapped themselves or generate HCC-mapped complications. Every H20.013 encounter should trigger a review of the full HCC opportunity landscape.

HCC-Mapped Conditions Associated with H20.013

ICD-10-CM	Description	HCC Status	HCC #	Bilateral Uveitis Relationship
M08.00-M08.99	Juvenile idiopathic arthritis	✅ HCC-40	Rheumatoid Arthritis/Inflammatory CTD	Most common cause of bilateral chronic anterior uveitis in children; bilateral > unilateral in polyarticular JIA
K50.x	Crohn’s disease	✅ HCC-35	Inflammatory Bowel Disease	IBD extraintestinal bilateral uveitis; HLA-B27 subset with bilateral disease
K51.x	Ulcerative colitis	✅ HCC-35	Inflammatory Bowel Disease	UC-associated anterior uveitis — can be bilateral
M45.0-M45.9	Ankylosing spondylitis	✅ HCC-40	CTD	Typically unilateral alternating; bilateral simultaneous AS uveitis less common but occurs
M07.x	Psoriatic arthropathy	✅ HCC-40	CTD	Psoriatic arthritis with bilateral anterior uveitis
G35.-	Multiple sclerosis	✅ HCC-77	Multiple Sclerosis	MS-associated bilateral intermediate/anterior uveitis overlap
M35.2	Behçet’s disease	✅ May map to HCC-40	CTD	Classic bilateral hypopyon uveitis; code with H20.013 or H20.053; NOT Excludes 1
M32.9	Systemic lupus erythematosus	✅ HCC-40	CTD	SLE-associated bilateral anterior uveitis
D86.0	Sarcoidosis of lung	✅ HCC-23 (contextual)	—	Sarcoid itself triggers D86.83 (Excludes 1) but pulmonary sarcoid adds HCC context
D86.83	Sarcoidosis of eye	Sarcoid systemic + HCC context	—	Most common cause of bilateral granulomatous uveitis in adults; Excludes 1 replaces H20.013
B20	HIV disease	✅ HCC-1	HIV/AIDS	Bilateral opportunistic uveitis in advanced HIV
Q93.81	22q11.2 deletion syndrome	✅ HCC-mapped (chromosomal)	—	Immune deficiency → recurrent/bilateral uveitis susceptibility
D84.9	Immunodeficiency, unspecified	✅ HCC-47	Immune Disorders	Immunocompromised state driving bilateral disease
N18.4	CKD Stage 4	✅ HCC-328	CKD	Relevant comorbidity affecting treatment decisions
E11.39	T2DM with other diabetic ophthalmic complication	✅ HCC-37	Diabetes	DM as comorbidity — not a cause of primary iridocyclitis
I69.391	Dysphasia following cerebral infarction	✅ HCC-146	Ischemic Stroke	Neurological comorbidity context
M02.30	Reactive arthritis (Reiter’s), unspecified	✅ HCC-40	CTD	Post-infectious bilateral anterior uveitis
A69.22	Lyme disease with other neurological complications	✅ HCC-75 (if neurological)	—	Lyme-associated bilateral uveitis — rare but reported

💡Pediatric HCC Note:

In the Medicare Advantage pediatric equivalent programs and HHS-HCC for pediatric exchange plans, bilateral uveitis in a child with JIA (M08.x = HCC-40) represents one of the highest-yield HCC coding opportunities in pediatric ophthalmology. The JIA diagnosis drives the RAF weight; the uveitis is the ocular manifestation. Ensure rheumatology and ophthalmology notes are synchronized and both are coding M08.x at every relevant encounter.

💡 Behçet's Bilateral Hypopyon — Double HCC Opportunity:

Behçet’s disease (M35.2) may map to HCC-40. When bilateral hypopyon uveitis (H20.053) is present in a patient with Behçet’s, the encounter involves multiple complex diagnoses. Code M35.2 at every encounter where it is documented and managed — the bilateral uveitis serves as the visible clinical indicator that this systemic vasculitis is active.

---

MS-DRG Assignment (Inpatient Facility)

Bilateral iridocyclitis (H20.013) has a higher inpatient admission likelihood than unilateral disease given:

• Greater simultaneous visual threat (both eyes at risk)
• More frequent underlying systemic disease requiring inpatient-level workup or treatment
• IV steroid initiation for sarcoidosis, VKH, or Behçet’s
• Bilateral hypopyon requiring urgent ophthalmologic management

MDC 02 DRG Mapping (H20.013 as Principal Diagnosis)

MS-DRG	Description	CC/MCC Tier
124	Other Disorders of the Eye with MCC	MCC present
125	Other Disorders of the Eye without MCC	No MCC

Note

💡 H20.013 (bilateral) maps to the same MDC 02 DRG family (124/125) as its unilateral counterparts (H20.011/H20.012). The bilateral designation does not independently shift DRG tier — however, the systemic conditions most commonly associated with bilateral uveitis do generate higher-weighted DRGs when they are the principal diagnosis.

Alternate DRG Pathways When Systemic Disease Drives Admission (Bilateral Uveitis as Secondary)

Underlying Condition	Principal Diagnosis Code	MS-DRG Family	MDC	DRG Weight Impact
Sarcoidosis (confirmed → D86.83)	D86.0 / D86.9 (pulmonary/systemic)	DRG 200-203 (Respiratory Neoplasm/Sarcoid)	MDC 04	Higher weight than MDC 02
JIA flare with bilateral uveitis	M08.x	DRG 553-555 (Bone Disease/Arthropathy)	MDC 08	Moderate weight
IBD flare with bilateral uveitis	K50.x / K51.x	DRG 385-387 (IBD)	MDC 06	Moderate weight
Behçet’s disease with hypopyon	M35.2	DRG 545-547 (Connective Tissue Disorders)	MDC 17	Higher weight
Syphilis (confirmed → A51.43)	A51.0 / A51.43	DRG 865-866 (Viral Illness) / MDC 18	MDC 18	Variable
Sepsis complicating bilateral device-related or severe uveitis	A41.x	DRG 870-872 (Sepsis)	MDC 18	Highest weight
VKH syndrome + CNS involvement	H20.823 + G03.9 (aseptic meningitis)	MDC 01 Neurology	MDC 01	High weight
HIV + bilateral CMV/opportunistic uveitis	B20 + B25.x	DRG 974-977 (HIV)	MDC 25	High weight

CC/MCC Codes That Shift DRG Tier for H20.013 Admissions

Code	Description	CC/MCC
A41.x	Sepsis	MCC
R65.20	Severe sepsis without shock	MCC
R65.21	Severe sepsis with shock	MCC
J96.00	Acute respiratory failure	MCC
H40.403	Secondary glaucoma, bilateral	CC
N17.9	Acute kidney injury	CC
G03.9	Meningitis (aseptic — VKH meningeal phase)	MCC
H35.813	Bilateral CME	CC
M35.2	Behçet’s disease	CC
K50.90	Crohn’s disease	CC
M08.x	JIA	CC
D86.0	Sarcoidosis of lung	CC
E87.1	Hyponatremia	CC

---

Associated CPT Procedure Codes & wRVU Values

Since H20.013 is a diagnosis code, the following represents CPT procedures commonly billed for bilateral iridocyclitis evaluation and management. The key billing distinction from H20.011/H20.012: bilateral procedures require modifier -50 or separate line items with -RT and -LT — verify payer preference, as many commercial payers and MACs prefer -50 while some prefer two line items.

Bilateral Modifier Guidance Summary

Payer Type	Preferred Billing Method for Bilateral Procedures
Medicare (most MACs)	Modifier -50 on a single line item; units = 1; payer adjusts to 150% fee schedule
Commercial payers (many)	Two separate line items: one with -RT, one with -LT; full fee for each or at payer-specified rate
Medicaid (state-specific)	Verify state Medicaid provider manual — varies significantly
Facility/hospital outpatient	Institutional billing may handle bilaterality differently than professional claims

Evaluation & Management

CPT	Description	2026 wRVU (est.)	Global Period	Notes
92004	Ophthalmological services, new patient, comprehensive	2.33	000	New patient bilateral iridocyclitis evaluation — single E/M code covers bilateral exam
92002	Ophthalmological services, new patient, intermediate	1.12	000	Abbreviated bilateral new patient evaluation
92014	Ophthalmological services, established patient, comprehensive	1.97	000	🔑 Most common — bilateral uveitis follow-up management
92012	Ophthalmological services, established patient, intermediate	0.97	000	Limited bilateral follow-up
99205	New patient E/M, high complexity	3.50	000	When E/M framework used over ophthalmologic-specific codes
99215	Established patient E/M, high complexity	2.85	000	High-complexity bilateral uveitis established patient
99223	Initial hospital care, high complexity	3.86	000	Inpatient admission — bilateral uveitis with systemic workup
99233	Subsequent inpatient E/M, high complexity	2.00	000	Inpatient follow-up; rheumatology, ID, ophthalmology all may bill this

💡 E/M Code Bilateral Note: The ophthalmological E/M codes (92004, 92014) inherently encompass bilateral examination — they are NOT doubled when both eyes are examined. A single 92014 covers the comprehensive evaluation of both eyes, including bilateral slit-lamp, bilateral IOP, bilateral dilated fundus. The bilateral designation affects diagnostic procedure codes, not E/M codes.

Diagnostic Procedures (Bilateral — With Modifier Guidance)

CPT	Description	2026 wRVU (est.)	Global Period	Bilateral Modifier	Notes
92020-50	Gonioscopy, bilateral	0.48 × 1.5 = 0.72	000	-50 or -RT/-LT	🔑 Angle assessment both eyes — critical for bilateral IOP elevation/secondary glaucoma
92134-50	OCT - posterior segment/macula, bilateral	0.52 × 1.5 = 0.78	000	-50 or -RT/-LT	🔑 Bilateral CME detection — mandatory in bilateral uveitis follow-up
92133-50	OCT - optic nerve, bilateral	0.52 × 1.5 = 0.78	000	-50 or -RT/-LT	Bilateral optic nerve monitoring when bilateral elevated IOP suspected
92235-50	Fluorescein angiography, bilateral	1.26 × 1.5 = 1.89	000	-50 or -RT/-LT	Bilateral posterior segment involvement; bilateral CME; bilateral disc leakage
92240-50	ICG angiography, bilateral	1.38 × 1.5 = 2.07	000	-50 or -RT/-LT	Bilateral choroidal assessment — granulomatous/VKH/sarcoid workup
92250-50	Fundus photography, bilateral	0.44 × 1.5 = 0.66	000	-50 or -RT/-LT	Baseline bilateral disc/macula documentation
92083-50	Visual field examination, extended, bilateral	0.42 × 1.5 = 0.63	000	-50 or -RT/-LT	Bilateral glaucoma/optic nerve monitoring
92025	Computerized corneal topography (bilateral)	0.36 per eye	000	-50 or -RT/-LT	Bilateral corneal irregularity assessment
65800-50	Paracentesis of anterior chamber, bilateral	2.46 × 1.5 = 3.69	010	-50 or -RT/-LT	Bilateral aqueous PCR — rare but may be indicated when bilateral infectious etiology suspected
92100-50	Serial tonometry, bilateral	0.42 × 1.5 = 0.63	000	-50 or -RT/-LT	Bilateral IOP monitoring — steroid response and trabeculitis

Surgical / Interventional Procedures (Bilateral)

CPT	Description	2026 wRVU (est.)	Assistant Payable	Global Period	Bilateral Modifier
67028-50	Intravitreal injection, bilateral	0.59 × 1.5 = 0.89	No	000	-50 or separate -RT/-LT
66984-50	Cataract surgery, bilateral	10.32 × 1.5 = 15.48	Yes - Ind. 1	090	-50 or -RT/-LT — sequential vs. simultaneous billing rules apply
66985-50	Secondary IOL, bilateral	10.32 × 1.5 = 15.48	Yes - Ind. 1	090	-50 or -RT/-LT
65820-50	Goniotomy, bilateral	6.57 × 1.5 = 9.86	Yes - Ind. 1	090	-50 or -RT/-LT
66170-50	Trabeculectomy with MMC, bilateral	14.30 × 1.5 = 21.45	Yes - Ind. 1	090	-50 or -RT/-LT — note: bilateral same-session trabeculectomy is uncommon
67041-50	Pars plana vitrectomy, bilateral	14.82 × 1.5 = 22.23	Yes - Ind. 1	090	-50 or -RT/-LT — bilateral same-session PPV is rare; more likely staged

⚠️ Bilateral Cataract Surgery Billing Rules: Medicare and most payers do NOT allow bilateral same-session cataract surgery reimbursement at 150% — bilateral cataract extractions are almost always staged (right eye first, left eye at a later date — separate global periods). When staged, each surgery is billed independently with full fee. When performed on the same date (rare), the second eye carries a -51 modifier (multiple procedures) with reduced reimbursement. Confirm payer-specific bilateral cataract billing policy before billing.

Pharmacy / J-Codes (Bilateral Intravitreal)

HCPCS	Drug	Route	Unit Guidance for Bilateral
J3301	Triamcinolone acetonide	Intravitreal bilateral	Bill 2 units or bilateral modifier per payer
C9257	Dexamethasone implant (Ozurdex)	Intravitreal bilateral	Bill 2 units (one per eye)
J7313	Fluocinolone acetonide implant (Retisert)	Intravitreal surgical	Bill separately per eye — surgical implant
J7311	Fluocinolone acetonide injectable (Iluvien)	Intravitreal bilateral	Bill 2 units
J0178	Aflibercept (Eylea)	Intravitreal bilateral	Bill 2 units for bilateral injection

---

Common Modifiers for Associated CPT Codes

Modifier	Description	Application with H20.013 (Bilateral) Context
-50	Bilateral Procedure	🔑 Primary bilateral modifier — applied to diagnostic and procedural codes when the identical procedure is performed on both eyes in the same session (OCT, gonioscopy, intravitreal injection, fundus photography); typically reduces reimbursement to 150% of single-eye fee
-RT	Right Side	Required when separately itemizing bilateral procedures by eye (two-line-item approach instead of -50); apply to right eye line
-LT	Left Side	Apply to left eye line item when using two-line vs. -50 approach
-25	Significant, Separately Identifiable E/M	When comprehensive bilateral E/M (92014) is performed same date as bilateral diagnostic procedures (92020-50, 92134-50); append to E/M code per payer guidelines
-59	Distinct Procedural Service	NCCI override for separately reportable bilateral procedures that may be bundled; verify PTP edits
-KX	Medical Necessity Documentation on File	Required by many MACs on bilateral OCT (92134-50 or 92134-RT and 92134-LT); H20.013 is a covered indication on most MAC OCT LCDs; check your MAC requirement
-52	Reduced Services	Abbreviated bilateral examination when patient unable to cooperate fully (severe photophobia, pain, pediatric patient)
-57	Decision for Surgery	On E/M code when decision for bilateral surgery (e.g., bilateral cataract extraction plan initiated) is made at this visit
-51	Multiple Procedures	If bilateral same-session surgical procedures performed — second procedure reduced by 50% per Medicare multiple procedure policy
-79	Unrelated Procedure During Global	Unrelated bilateral procedure during global period of prior eye surgery

---

Coding Examples / Scenarios

---

Scenario 1 - First-Episode Bilateral Acute Iridocyclitis, No Etiology Confirmed (Outpatient)

Clinical Situation: A 42-year-old African American female presents to an ophthalmologist with 4 days of bilateral eye redness, pain, and photophobia. Slit-lamp examination reveals 2+ cells and 1+ flare bilaterally, with medium-sized KPs bilaterally. IOP: Right 16 mmHg, Left 18 mmHg. Dilated fundus exam: bilateral posterior vitreous cells, right disc edema. No systemic history documented. Workup ordered: ACE, serum lysozyme, CXR, ANA, HLA-B27, RPR, QuantiFERON-TB.

ICD-10-CM:

• H20.013 - Primary iridocyclitis, bilateral (first-listed — first episode, no etiology confirmed, bilateral simultaneous; medium-sized KPs suggest granulomatous — sarcoid high on differential but not yet confirmed)

CPT:

• 92004 - Ophthalmological services, new patient, comprehensive (single code for bilateral examination — not doubled)
• 92020-50 - Gonioscopy, bilateral (angle assessment both eyes)
• 92134-50 - OCT, retina/macula, bilateral (CME and posterior segment assessment)

✅ H20.013 is appropriate here. Medium-sized KPs raise concern for granulomatous etiology (sarcoidosis); update the code to D86.83 if sarcoidosis is confirmed. The comprehensive new patient ophthalmological exam (92004) covers the bilateral examination in a single code.

---

Scenario 2 - Workup Returns Sarcoidosis Confirmed: Code Transition

Clinical Situation: The same patient from Scenario 1 returns 3 weeks later. CXR shows bilateral hilar adenopathy; serum ACE is elevated at 98 U/L; bronchoscopy with BAL was performed by pulmonology with noncaseating granulomas confirmed on biopsy. Diagnosis: Pulmonary sarcoidosis with bilateral sarcoid uveitis.

Updated ICD-10-CM:

• D86.83 - Sarcoidosis of eye (replaces H20.013 — sarcoidosis is Excludes 1; D86.83 captures the bilateral ocular sarcoid without needing a laterality sub-code)
• D86.0 - Sarcoidosis of lung (additional — pulmonary sarcoidosis; the pulmonary component)

⚠️ H20.013 must be discontinued when D86.83 is assigned. D86.83 is Excludes 1 from H20.0x — they cannot coexist. D86.83 inherently captures the bilateral ocular sarcoidosis in a single code. Do not add H20.013 alongside D86.83.

💡 DRG Impact of Code Transition: When the principal diagnosis shifts from H20.013 (MDC 02 — DRG 124/125, low weight) to D86.0 (MDC 04 — respiratory/sarcoid DRG, higher weight) for an inpatient case, the reimbursement impact can be significant. Accurate and timely code updating is critical for both clinical accuracy and facility reimbursement.

---

Scenario 3 - Bilateral Iridocyclitis in JIA Child (Pediatric)

Clinical Situation: An 8-year-old female with known polyarticular JIA (ANA positive, RF negative) presents for routine ophthalmologic screening. No eye symptoms reported. Slit-lamp reveals 1+ cells, 1+ flare bilaterally. Duration of bilateral AC activity has been documented over 4 months now. Managed on topical prednisolone + methotrexate systemically.

ICD-10-CM:

• H20.13 - Chronic iridocyclitis, bilateral (NOT H20.013 — duration is 4 months; chronic threshold of 3 months per SUN criteria has been crossed)
• M08.40 - Pauciarticular juvenile idiopathic arthritis, unspecified site (or M08.00 for polyarticular RF-negative — specify per documentation; HCC-40)
• Z79.3 - Long-term (current) use of systemic steroids (if applicable)
• Z79.899 - Long-term (current) use of other medications (methotrexate)

💡 JIA Bilateral Chronic Uveitis is the prototypical use case where the acute bilateral code (H20.013) should have transitioned to chronic bilateral (H20.13) once duration exceeded 3 months. Many JIA-associated uveitis cases are diagnosed at routine screening visits — not because the child is symptomatic — because JIA uveitis is classically asymptomatic. Ongoing documentation of AC cell grade at each visit is required for continued medical necessity of topical steroids and systemic immunosuppression.

---

Scenario 4 - Bilateral Hypopyon: Behçet’s Disease

Clinical Situation: A 33-year-old male of Middle Eastern descent presents with severe bilateral eye pain, photophobia, and markedly decreased vision. Slit-lamp reveals 4+ cells, 4+ flare bilaterally with bilateral layered hypopyon (right eye 3mm, left eye 2mm hypopyon). He also reports active oral ulcers (3) and a healing genital ulcer. Rheumatology is consulted and diagnoses Behçet’s disease.

ICD-10-CM:

• M35.2 - Behçet’s disease (first-listed — the principal systemic diagnosis driving the inpatient admission)
• H20.053 - Hypopyon, bilateral (the specific ocular manifestation — more specific than H20.013 since hypopyon is documented; Behçet’s is NOT Excludes 1 from H20.05x)

⚠️ Behçet’s disease (M35.2) is NOT in the Excludes 1 list for H20.0x. Unlike sarcoidosis (D86.83) or syphilis (A51.43), Behçet’s does not have an eye-specific subcode in the ICD-10-CM that replaces H20.0x. Therefore, both M35.2 (the systemic disease) and H20.053 (the specific hypopyon complication) are correctly coded together. This is a critical distinction from the Excludes 1 scenarios.

⚠️ Hypopyon Overrides H20.013. When bilateral hypopyon is documented, use H20.053 (hypopyon, bilateral) rather than H20.013. Do not report both H20.053 and H20.013 for the same bilateral episode — hypopyon is the more specific and clinically severe designation.

---

Scenario 5 - Bilateral Uveitis: Recurrent Acute, Code Upgrade

Clinical Situation: A 36-year-old male with IBD (Crohn’s disease, K50.90) presents with a third episode of bilateral anterior uveitis over 18 months. Each episode has resolved fully with topical treatment. The ophthalmologist documents “recurrent acute bilateral anterior uveitis, third episode, secondary to Crohn’s disease.”

ICD-10-CM:

• H20.043 - Secondary noninfectious iridocyclitis, bilateral (the uveitis is secondary noninfectious — etiology confirmed as Crohn’s)
• K50.90 - Crohn’s disease, unspecified, without complications (the underlying systemic disease — HCC-35)

✅ Two code upgrades applied here:

1. Primary → Secondary noninfectious: Crohn’s disease is confirmed → H20.043 (not H20.013 and not H20.023)
2. Even though this is a third recurrent episode: once the systemic etiology is confirmed (Crohn’s), the code is H20.043 (secondary noninfectious), not H20.023 (recurrent acute, which is used when the recurrent pattern is established but no etiology confirmed)

---

Scenario 6 - VKH Syndrome: Bilateral Anterior + Posterior Uveitis

Clinical Situation: A 28-year-old South Asian female presents with acute bilateral decreased vision, bilateral eye redness and pain, headache, tinnitus, and hearing loss. Funduscopic exam shows bilateral exudative retinal detachments and bilateral disc edema. Anterior chamber shows bilateral 2+ cells. Diagnosis: Vogt-Koyanagi-Harada (VKH) syndrome, bilateral.

ICD-10-CM:

• H20.823 - Vogt-Koyanagi-Harada syndrome, bilateral (replaces H20.013 — VKH has its own specific code; more specific than H20.013)
• H30.93 - Unspecified chorioretinal inflammation, bilateral (the posterior component of VKH — bilateral exudative retinal detachments and chorioretinitis)

⚠️ When VKH syndrome is confirmed, H20.823 replaces H20.013 entirely. VKH is not in the Excludes 1 list for H20.0x — it has its own specific code under H20.82x which should be used over the generic H20.013 for specificity and clinical accuracy. H20.013 would be appropriate during the initial evaluation before VKH is confirmed; once established, upgrade to H20.823.

---

Scenario 7 - Bilateral Intravitreal Injection for Uveitic CME

Clinical Situation: A 47-year-old male with chronic bilateral iridocyclitis (H20.13) secondary to sarcoidosis (D86.83) has developed bilateral cystoid macular edema. OCT confirms bilateral CME (right eye CST 390μm, left eye CST 420μm). Bilateral intravitreal Ozurdex (dexamethasone 0.7mg implant) injections are performed.

CPT:

• 92014 - Established patient, comprehensive ophthalmological exam (single E/M covering both eyes)
• 92134-50 - OCT, retina/macula, bilateral (modifier -50)
• 67028-50 - Intravitreal injection, bilateral (modifier -50 — OR two line items: 67028-RT and 67028-LT)
• C9257 × 2 - Dexamethasone intravitreal implant, 0.7mg (bill 2 units — one per eye)

ICD-10-CM:

• D86.83 - Sarcoidosis of eye (primary diagnosis — Excludes 1 replaces H20.13/H20.013 in this chronic sarcoid uveitis case)
• D86.0 - Sarcoidosis of lung (if pulmonary involvement documented and managed)
• H35.813 - Cystoid macular edema, bilateral (the specific complication driving the intravitreal treatment)

💡 Bilateral -50 vs. Two Line Items: For 67028 (intravitreal injection), Medicare generally accepts modifier -50 on a single line with units = 1 and the fee schedule is paid at 150% of the single-eye allowable. Many commercial payers prefer two separate line items (67028-RT and 67028-LT) for clarity and adjudication. Bill C9257 with 2 units to reflect 2 implants. Verify your specific MAC and commercial payer policies — mismatch between the modifier approach and payer adjudication rules is a common source of claim denial for bilateral injections.

---

Scenario 8 - ED Presentation: Bilateral Acute Iritis, Unknown Etiology

Clinical Situation: A 19-year-old male presents to the emergency department with sudden bilateral eye pain and redness that developed over several hours. Emergency physician confirms bilateral anterior chamber reaction on slit-lamp. Vital signs stable. No systemic complaints documented. Patient referred urgently to ophthalmology and prescribed topical prednisolone and cyclopentolate bilaterally.

ICD-10-CM (ED Claim):

• H20.013 - Primary iridocyclitis, bilateral (bilateral acute iritis = bilateral iridocyclitis = H20.013 when no etiology confirmed)

CPT (ED):

• 99284 or 99285 - Emergency department E/M (moderate-high or high complexity given bilateral visual threat)

✅ H20.013 is appropriate in the ED setting for bilateral acute iritis without confirmed etiology. The bilateral simultaneous presentation should increase clinical urgency for systemic workup — an ophthalmology referral note documenting bilateral onset is appropriate documentation for the H20.013 code.

---

Scenario 9 - Syphilitic Bilateral Uveitis: Excludes 1 Override

Clinical Situation: A 31-year-old immunocompromised male (HIV-positive, B20) presents with bilateral eye pain and decreased vision. RPR titer is 1:256; FTA-ABS is reactive. Syphilis is confirmed. Bilateral anterior uveitis is documented as secondary syphilitic iridocyclitis.

ICD-10-CM:

• A51.43 - Syphilitic oculopathy, secondary (Excludes 1 — replaces H20.013 entirely for bilateral syphilitic anterior uveitis)
• B20 - HIV disease (HCC-1 — underlying immunocompromised state; must always be coded when documented)

⚠️ H20.013 must be completely omitted when A51.43 is coded. These are Excludes 1 — mutually exclusive. Syphilis as a confirmed etiology bypasses the entire H20.0x code family. Note that this patient also carries HCC-1 (HIV/AIDS) — the H20.013 encounter, though not HCC-generating itself, triggered a workup that confirmed and captured an HCC-1 condition.

---

Scenario 10 - Bilateral Asymmetric Activity: When NOT to Use H20.013

Clinical Situation: A 44-year-old female with established right-eye chronic iridocyclitis (H20.11) presents for follow-up. The right eye shows 1+ cells (stable). Examination of the left eye reveals a new acute flare with 3+ cells and 2+ flare — first left eye episode. The right eye is chronically inflamed; the left eye has a new acute episode.

ICD-10-CM:

• H20.11 - Chronic iridocyclitis, right eye (the established chronic right eye condition)
• H20.012 - Primary iridocyclitis, left eye (the new acute left eye episode — first episode left eye)

⚠️ Do NOT use H20.013 here. Although both eyes are inflamed, they are in different clinical states: the right eye has chronic iridocyclitis (H20.11) and the left eye has new acute primary iridocyclitis (H20.012). When eyes are in different stages or phases of the disease, each eye is coded to its own specific subcategory rather than collapsing both into the bilateral H20.013 code. H20.013 is only appropriate when both eyes are in the same clinical category (both acute primary iridocyclitis simultaneously).

---

Documentation Requirements

For accurate bilateral coding, medical necessity support, and audit defense, documentation should explicitly include:

• Bilateral designation clearly stated: “Bilateral anterior uveitis,” “bilateral iridocyclitis,” or equivalent — in the assessment/diagnosis line
• Simultaneous confirmation: That both eyes are active at the same encounter — bilateral code is only appropriate when both eyes are currently active, not when sequentially affected
• Per-eye clinical findings: AC cells and flare grade (SUN scale) documented separately for right and left eye — e.g., “Right: 2+ cells, 1+ flare; Left: 3+ cells, 2+ flare”
• KP characteristics per eye: Fine/stellate vs. mutton-fat — bilateral granulomatous KPs strongly suggest sarcoidosis, TB, VKH; demands immediate systemic workup
• Hypopyon documentation: If present in either or both eyes — triggers H20.051/052/053 code; also triggers Behçet’s and bacterial endophthalmitis differential
• IOP per eye: Both eyes documented at every visit
• Dilated fundus exam bilateral: Vitreous cells, disc edema, exudative detachments (VKH), CME — posterior findings change clinical category and diagnostic urgency
• Asymmetric severity documentation: When severity differs between eyes, document each eye separately to support accurate code selection (bilateral vs. separate unilateral codes for different states)
• Etiologic workup status: Specific tests ordered, pending, resulted — and whether a systemic diagnosis has been confirmed; determines whether H20.013 should be transitioned to D86.83, A51.43, H20.043, H20.823, etc.
• Systemic review of systems: Pulmonary symptoms (sarcoid), GI symptoms (IBD), joint pain (AS, JIA, ReA), skin lesions (psoriasis, sarcoid skin, Behçet’s), genital/oral ulcers (Behçet’s, syphilis), constitutional symptoms (VKH, TB, lymphoma)
• Recurrence history: Prior bilateral episodes — supports upgrade to H20.023 (recurrent acute bilateral)
• Duration of bilateral activity: If ≥ 3 months continuously → supports upgrade to H20.13 (chronic bilateral)
• Treatment plan bilateral specifics: Topical steroids per eye, cycloplegics, systemic therapy initiated — bilateral treatment supports bilateral procedure billing
• Multidisciplinary team documentation: Rheumatology, infectious disease, gastroenterology, pulmonology consultations — capture all consulting specialists’ diagnoses for complete HCC coding

---

Coding Tips & Pitfalls

💡 H20.013 ≠ H20.011 + H20.012. The single most common billing error for bilateral primary iridocyclitis is dual-coding H20.011 and H20.012 simultaneously for the same bilateral episode. This is incorrect — use H20.013 (bilateral) as a single code when both eyes are simultaneously affected at the same clinical level. The only scenario where H20.011 and H20.012 are reported together is when each eye is in a different clinical category (e.g., right eye chronic, left eye acute — as shown in Scenario 10 above).

💡 Bilateral simultaneous uveitis is a systemic disease red flag. While HLA-B27-associated uveitis (the most common overall cause of anterior uveitis) is characteristically unilateral and alternating, bilateral simultaneous anterior uveitis demands an expanded differential that prioritizes sarcoidosis, JIA, syphilis, VKH, and Behçet’s. The coding consequence: many of these etiologies carry Excludes 1 status (sarcoidosis = D86.83; syphilis = A51.43/A52.71; TB = A18.54), meaning H20.013 becomes incorrect the moment the etiology is confirmed. Build a code audit trigger into the workflow whenever H20.013 appears to ensure workup results are reviewed and codes are updated.

💡 Granulomatous KPs in both eyes = sarcoid until proven otherwise. Mutton-fat KPs are a clinical hallmark of granulomatous anterior uveitis. When documented bilaterally, sarcoidosis should be at the top of the differential. If sarcoidosis is confirmed — even weeks after the initial encounter — update all active claims to D86.83 and remove H20.013. Retrospective code correction is appropriate and required for billing accuracy.

💡 Bilateral -50 modifier: confirm payer adjudication before billing. Modifier -50 for bilateral procedures (92134-50, 67028-50) is adjudicated differently across payers. Medicare typically pays 150% of the single-eye allowable on -50 claims. Some commercial payers require two separate line items with -RT/-LT for proper bilateral reimbursement. Billing -50 to a payer that requires -RT/-LT will result in denial or single-eye payment. Verify your top payers’ bilateral billing policies and configure accordingly in your billing system.

💡 VKH syndrome bilateral = H20.823 — always more specific than H20.013. VKH is almost always bilateral by definition. When VKH is confirmed, transition from H20.013 to H20.823 (VKH syndrome, bilateral). H20.823 is not in the Excludes 1 list of H20.0x — it exists as a sibling code within H20.8. Using H20.823 over H20.013 is a specificity upgrade, not a mutual exclusion — but best practice (and accurate coding) demands using the most specific code available.

💡 Behçet’s bilateral hypopyon = M35.2 + H20.053 — NOT Excludes 1. Behçet’s disease is one of the few major systemic causes of bilateral anterior uveitis that does NOT appear in the Excludes 1 list for H20.0x. When Behçet’s is confirmed with bilateral hypopyon, the correct coding is M35.2 (Behçet’s) + H20.053 (hypopyon, bilateral). Both codes are simultaneously reportable. Do not make the mistake of treating Behçet’s like sarcoidosis or syphilis — they have different Excludes 1 status.